Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression.
about
Cactus pear: a natural product in cancer chemopreventionVitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteinsDecrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell lineRetinoids: present role and future potential.The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.Retinoids and ovarian cancer.AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.Fenretinide activates caspases and induces apoptosis in gliomas.Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology GroupFenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions.Fenretinide: a prototype cancer prevention drug.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.Flow Cytometric Analysis of 4-HPR-induced Apoptosis and Cell Cycle Arrest in Acute Myelocytic Leukemia Cell Line (NB-4).Fenretinide induces ubiquitin-dependent proteasomal degradation of stearoyl-CoA desaturase in human retinal pigment epithelial cells.Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro.Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.Effect of 4-hydroxyphenylretinamide on human cervical epithelial and cancer cell lines.Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.Selective activation of an apoptotic retinoid precursor in macrophage cell lines.Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide.Cytochrome c oxidase subunit III: a molecular marker for N-(4-hydroxyphenyl)retinamise-induced oxidative stress in hepatoma cells.Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells.A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis.Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide.Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth.Apoptosis of Human Neuroblastoma Cells Induced by Liposome-Encapsulated FenretinideThe Chemoprevention of Ovarian Cancer: the Need and the Options
P2860
Q21245909-B33DCB12-464F-4159-9309-A339970472FFQ28081177-7B60C7BF-948B-48D3-83C8-E02A9BBD2BD5Q28366043-A466389C-AF07-42DD-B8BB-E38C02E010F3Q33676667-3DB99171-2FDE-43EA-814A-5A6ECB72A0D9Q33724839-550AABCA-A058-4495-A230-CFBAB09196FBQ34002981-44914786-0B40-4200-8BAA-ED522AA94C4CQ34326688-6EFD88B2-3F98-49B4-A4F7-843080B67DAAQ34876630-717F629F-4837-42BB-A01F-C0040503E9D6Q35511099-6DD0D553-76A5-499A-8B25-1905D94D2FF7Q35562797-76844EA2-3623-4EF2-B565-938975E6C9BFQ35570960-DC7491DA-420A-47F0-B0CD-BC7FAEE6129CQ36313479-86B44F2F-205C-4C42-B58C-C1DB0EBE1236Q36571283-691259AC-8253-4474-99EB-204EE977D3B3Q37722398-9BED9446-45C4-4DF7-9CB8-BD34327EB0F6Q39511962-93F6132B-4F4E-4679-8EA3-F5E4D0BF6FEDQ40042153-F9CE0220-6919-4785-B2EB-18AD9BA90381Q40184776-DFAEEE6F-F6DD-47C1-883B-E6F2C492FE3CQ40612715-D19FB726-BE48-474B-B816-9747554B1CBFQ40679037-6A28D4B8-3307-4BC1-ABB8-5DE3056640D9Q40693110-EEE53385-D02E-4A61-95DE-C4C8C612A9D0Q40703405-75901B71-66E2-4F99-B0A9-C5F0F644F8ECQ41018777-6FF82D28-33C9-4A2F-92B7-F9F0F118CEF7Q41049278-365664F6-1E60-456C-B6B3-04B978DA472BQ43792252-2548857B-8D31-46EF-9691-654A50582105Q44068904-2AB152DC-F961-4166-B33E-85410A74A8C6Q44251894-0E1D57D2-9DCA-4AC5-8D39-E8FD8650AAC0Q46459242-E26DE01C-B05F-4E78-8F89-97B71A46C363Q46947417-BA4DEDBB-0FCB-4E67-9B97-314C81A208A6Q53436090-F4093C5E-79E3-44A4-8FD1-3DB774354B76Q57980420-C49E5B64-36EE-4F39-8D6B-83601249B0AFQ58579152-9BE5E5A1-38BA-43C2-8E06-BB7365878175
P2860
Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Induction of apoptosis by fenr ...... noic acid receptor expression.
@en
type
label
Induction of apoptosis by fenr ...... noic acid receptor expression.
@en
prefLabel
Induction of apoptosis by fenr ...... noic acid receptor expression.
@en
P2093
P1476
Induction of apoptosis by fenr ...... noic acid receptor expression.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19960208)65:4<491::AID-IJC17>3.0.CO;2-D
P577
1996-02-01T00:00:00Z